Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized open-label trial of interferon beta-1a in hospitalized COVID-19 patients
2020-002458-25Phase 2Terminated
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Aug 2020
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in coronavirus disease 2019 (COVID-19) comparing Interferon beta-1a with Control (standard of care) (2 arms). Primary endpoint: Time to negative conversion of SARS-CoV-2 nasopharyngeal swab. Started Aug 2020; status: terminated.
02
Drugs
interferon beta-1a
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-002458-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002458-25.